In vivo studies, using ANRIL knockout mice, have revealed that diabetes-induced up-regulation of retinal VEGF, and increased retinal microvascular permeability, are prevented by the down-regulation of ANRIL. The gene discussed is CDKN2B-AS1; the disease is diabetes mellitus.